Translate this page into:
Toxic epidermal necrolysis - Managed successively in a remote rural hospital in Assam
*For correspondence: mail4shajin@gmail.com
-
Received: ,
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
A seven yr old male child† presented to department of Pediatrics, Makunda Christian Leprosy & General Hospital, Assam, India, during June 2018, with skin lesions all over the body. He was diagnosed to have toxic epidermal necrolysis (Fig. 1). He was managed with supportive care including dressings and nasogatric feeds, stopping the offending drug (cephalosporin) and by treating the infection. Eye care was also given, as it can be sight threatening. Corticosteroid was given during the acute management and the child went home normally (Fig. 2). He was followed up after two weeks at the review OPD and was found to be doing well. The incidence of toxic epidermal necrolysis is 1-2 cases per million population. The skin lesions and the risk of superadded skin infection can be life threatening. Toxic epidermal necrolysis can be managed in a secondary level hospital setting successively.
- Skin lesions of the child at admission.
- The resolution of skin lesions at discharge.
Conflicts of Interest: None.
